» Articles » PMID: 33004797

Discovery of Gramicidin A Analogues with Altered Activities by Multidimensional Screening of a One-bead-one-compound Library

Overview
Journal Nat Commun
Specialty Biology
Date 2020 Oct 2
PMID 33004797
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Gramicidin A (1) is a peptide antibiotic that disrupts the transmembrane ion concentration gradient by forming an ion channel in a lipid bilayer. Although long used clinically, it is limited to topical application because of its strong hemolytic activity and mammalian cytotoxicity, likely arising from the common ion transport mechanism. Here we report an integrated high-throughput strategy for discovering analogues of 1 with altered biological activity profiles. The 4096 analogue structures are designed to maintain the charge-neutral, hydrophobic, and channel forming properties of 1. Synthesis of the analogues, tandem mass spectrometry sequencing, and 3 microscale screenings enable us to identify 10 representative analogues. Re-synthesis and detailed functional evaluations find that all 10 analogues share a similar ion channel function, but have different cytotoxic, hemolytic, and antibacterial activities. Our large-scale structure-activity relationship studies reveal the feasibility of developing analogues of 1 that selectively induce toxicity toward target organisms.

Citing Articles

Antibiotics: From Mechanism of Action to Resistance and Beyond.

Saikia S, Chetia P Indian J Microbiol. 2024; 64(3):821-845.

PMID: 39282166 PMC: 11399512. DOI: 10.1007/s12088-024-01285-8.


The microbiome-derived antibacterial lugdunin acts as a cation ionophore in synergy with host peptides.

Berscheid A, Straetener J, Schilling N, Ruppelt D, Konnerth M, Schittek B mBio. 2024; 15(9):e0057824.

PMID: 39133006 PMC: 11389392. DOI: 10.1128/mbio.00578-24.


Costunolide Inhibits Chronic Kidney Disease Development by Attenuating IKKβ/NF-κB Pathway.

Zhao Y, Wang Y, Tu W, Wang D, Lu M, Shao Y Drug Des Devel Ther. 2024; 18:2693-2712.

PMID: 38974121 PMC: 11227330. DOI: 10.2147/DDDT.S466092.


Microbial- and Plant-Derived Bioactive Peptides and Their Applications against Foodborne Pathogens: Current Status and Future Prospects.

Parvez A, Jubyda F, Ayaz M, Sarker A, Haque N, Khan M Int J Microbiol. 2024; 2024:9978033.

PMID: 38716460 PMC: 11074716. DOI: 10.1155/2024/9978033.


Genomic Based Analysis of the Biocontrol Species : A Model Resource of Structurally Diverse Pharmaceuticals and Biopesticides.

Al-Salihi S, Alberti F J Fungi (Basel). 2023; 9(9).

PMID: 37755004 PMC: 10532697. DOI: 10.3390/jof9090895.


References
1.
Koehn F, Carter G . The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 2005; 4(3):206-20. DOI: 10.1038/nrd1657. View

2.
Li J, Vederas J . Drug discovery and natural products: end of an era or an endless frontier?. Science. 2009; 325(5937):161-5. DOI: 10.1126/science.1168243. View

3.
Harvey A, Edrada-Ebel R, Quinn R . The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015; 14(2):111-29. DOI: 10.1038/nrd4510. View

4.
Newman D, Cragg G . Natural Products as Sources of New Drugs from 1981 to 2014. J Nat Prod. 2016; 79(3):629-61. DOI: 10.1021/acs.jnatprod.5b01055. View

5.
Moloney M . Natural Products as a Source for Novel Antibiotics. Trends Pharmacol Sci. 2016; 37(8):689-701. DOI: 10.1016/j.tips.2016.05.001. View